Today, a brief rundown of news involving City Therapeutics and Grin Therapeutics, as well as updates from Savara Pharma, Aurion Biotech and Prothena that you may have missed.

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it has raised $20.3 million in new funding to scale up its U.S. presence ...

The Garden State is looking to grow into the next big biotech hub. The New Jersey Innovation Hub has tapped venture capital firm Portal Innovations to build a 30,000-square-foot incubator lab ...

Reuters spoke to seven biotech executives, investors, and consultants who said that the staff departures and policy changes at the FDA had prompted some firms to consider launching trials in other ...

Revvity also raised its sales outlook for the full year. Biotech firm Revvity (RVTY) posted first-quarter results that topped analysts' estimates. The company on Monday reported adjusted earnings ...

George Yancopoulos, co-founder of biotech company Regeneron, has purchased almost all of the condominium units in a mixed-use Tribeca building, according to city records made public this week.

The firm claimed the biotech market has seen a “significant shift” in recent years, leading to scarce investor financing for early-stage biotech firms. Battelle, a nonprofit Columbus-based ...

A biotech firm is expanding its global footprint with a major partnership that will bring its cell preservation technology to one of the world’s largest life sciences markets. Newcastle-based Atelerix ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

Then, state-backed entities scale up these innovations and pump capital into domestic biotech firms to corner and eventually overwhelm global supply chains with low-cost products. To ensure the United ...

Dallas-based biotech company Colossal says they’ve resurrected the giant Ice Age dire wolf species made famous on the television series “Game of Thrones” through a process called de-extinction.

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...